Package 70010-199-05

{"route": ["ORAL"], "spl_id": "1cba14de-cac6-e5f3-e063-6294a90ab154", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["495W7451VQ"], "rxcui": ["636522"], "spl_set_id": ["e6994e38-2a21-4bcf-e053-2995a90a0854"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["GRANULES PHARMACEUTICALS INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-199-05)", "package_ndc": "70010-199-05", "marketing_start_date": "20220819"}], "brand_name": "GUAIFENESIN", "product_id": "70010-199_1cba14de-cac6-e5f3-e063-6294a90ab154", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]"], "product_ndc": "70010-199", "generic_name": "GUAIFENESIN", "labeler_name": "GRANULES PHARMACEUTICALS INC.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "GUAIFENESIN", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "600 mg/1"}], "application_number": "ANDA213420", "marketing_category": "ANDA", "marketing_start_date": "20220819", "listing_expiration_date": "20261231"}